You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
|
|---|---|
| Published in |
Journal of Clinical Oncology, January 2024
|
| DOI | 10.1200/jco.23.01911 |
| Pubmed ID | |
| Authors |
Nicholas J. Short, Naval Daver, Courtney D. Dinardo, Tapan Kadia, Lewis F. Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia-Manero, Ghayas C. Issa, Kelly S. Chien, Elias Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J. Stojanik, Keyur P. Patel, Regina Abramova, Jennifer Thankachan, Marina Konopleva, Hagop Kantarjian, Farhad Ravandi |
X Demographics
The data shown below were collected from the profiles of 124 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 38 | 31% |
| India | 9 | 7% |
| Spain | 7 | 6% |
| United Kingdom | 3 | 2% |
| Brazil | 3 | 2% |
| Japan | 2 | 2% |
| Chile | 1 | <1% |
| Russia | 1 | <1% |
| Italy | 1 | <1% |
| Other | 9 | 7% |
| Unknown | 50 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 81 | 65% |
| Practitioners (doctors, other healthcare professionals) | 23 | 19% |
| Scientists | 19 | 15% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 15 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 3 | 20% |
| Other | 2 | 13% |
| Student > Doctoral Student | 2 | 13% |
| Student > Postgraduate | 2 | 13% |
| Researcher | 1 | 7% |
| Other | 1 | 7% |
| Unknown | 4 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 4 | 27% |
| Medicine and Dentistry | 4 | 27% |
| Nursing and Health Professions | 1 | 7% |
| Unknown | 6 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 118. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2024.
All research outputs
#366,879
of 25,941,588 outputs
Outputs from Journal of Clinical Oncology
#679
of 22,326 outputs
Outputs of similar age
#5,633
of 359,367 outputs
Outputs of similar age from Journal of Clinical Oncology
#8
of 200 outputs
Altmetric has tracked 25,941,588 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,326 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,367 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 200 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.